TRIPLE THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: A COMPARISON OF CLOPIDOGREL VERSUS PRASUGREL FROM THE TRANSLATE-ACS STUDY

While studies have found high bleeding rates when patients require triple antithrombotic therapy (oral anticoagulant, ADP receptor inhibitor and aspirin), there is limited information on the relative bleeding risks of clopidogrel vs. prasugrel in these regimens. We evaluated acute myocardial